Tubal Blockages: How They Are Diagnosed and When Surgery Helps

Less than it sounds, particularly when the blockage is proximal — at the point where the tube leaves the uterus. Hysterosalpingography is the right first test, and it is also a test with a well-documented tendency to report blockages that are not there.

ASRM's 2021 committee opinion on tubal surgery puts it directly: HSG should be considered the standard first-line test to assess tubal patency, but it is limited by false-positive diagnoses of proximal tubal blockage.

• Proximal blockage is the least reliable HSG finding.
• Tubal spasm during the procedure can mimic a true blockage.
• Distal findings such as hydrosalpinx are more reliable.
• One abnormal HSG rarely justifies a decision on its own.

The practical consequence is that a proximal blockage on a first HSG is a reason to repeat or confirm the test, not a reason to proceed straight to surgery or to abandon the tubes as a route to pregnancy.

By repeating or escalating the test rather than accepting the first result. A second HSG is the simplest step, and on the ASRM figures it resolves the majority of proximal findings without anything more invasive.

Laparoscopy with dye remains the reference standard because it looks at the tube directly rather than inferring patency from where contrast stops. It is also surgery, with the risks that carries, so it is not a first move.

• Repeat HSG — cheapest, resolves most proximal false positives.
• Laparoscopy with dye — direct view, reference standard, but surgical.
• Selective tubal cannulation — can both confirm and relieve proximal blockage.
• Ultrasound — useful for hydrosalpinx, not for patency generally.

Distal disease behaves differently. A hydrosalpinx — a tube blocked at the far end and distended with fluid — is usually visible on ultrasound as well as HSG, and it is the finding with the clearest consequences for treatment.

• Fertility Tests for Women: What Each One Checks, and When
• Endometriosis and IVF: What the Evidence Says About Surgery First
• PGT-A in IVF: What the Evidence Shows About Testing Embryos
• What Is Assisted Hatching — And Does the Evidence Support It? (2026)
• Can a Vasectomy Be Reversed?
• Infertility and Mental Health: How Common Distress Actually Is

Usually yes, where it communicates with the uterine cavity. Hydrosalpinges reduce pregnancy, implantation and delivery rates by approximately 50% in IVF cycles, which is a large enough effect that removing them changes the arithmetic of a cycle.

The Cochrane review by Melo and colleagues, updated in 2020, pooled four randomized trials covering 455 women. Salpingectomy probably increases clinical pregnancy rate versus no surgery, with a risk ratio of 2.02 and a 95% confidence interval of 1.44 to 2.82, rated moderate-quality evidence.

One caveat belongs beside that figure and is usually left out. No study in that comparison reported live birth. The effect is established on clinical pregnancy, and clinical pregnancy is not the outcome anyone is actually seeking.

ASRM's conclusion is that laparoscopic salpingectomy should be used for proximal tubal occlusion in cases of surgically irreparable hydrosalpinges to improve IVF pregnancy rates. Where the tube might be repaired, that is a different conversation.

In a narrower set of situations than surgeons once claimed and than IVF clinics now imply. ASRM identifies young women without other infertility factors who present with mild hydrosalpinges, unilateral proximal obstruction, or proximal blockage suitable for cannulation.

Reversal of sterilisation is the clearest case. ASRM reports that tubal anastomosis for sterilisation reversal shows higher cumulative pregnancy rates than IVF in women under 37 — 72% against 52%.

• Microsurgical anastomosis is the recommended technique for reversal.
• Pooled pregnancy rates run 65–68% across microsurgical, laparoscopic and robotic approaches.
• Age is the most significant prognostic factor.
• Women under 30 achieved 88% pregnancy rates.

Age drives that decision more than technique does. The same operation in a woman of 30 and a woman of 40 is not the same proposition, and the figures above belong to the younger end of the range.

Two claims recur in this area and neither holds up. The first treats one abnormal HSG as settled; the second treats tubal surgery and IVF as competing products rather than options suited to different findings.

• A single proximal blockage on HSG is not a confirmed blockage.
• Salpingectomy is not indicated for every hydrosalpinx regardless of type.
• Tubal flushing is not a treatment for a confirmed structural blockage.
• No supplement, massage or therapy has been shown to open a blocked tube.

The honest position is that tubal findings vary enormously in what they mean. Proximal and distal disease behave differently, one HSG is not a diagnosis, and the decision between surgery and IVF turns on age and on which part of the tube is affected. Our comparison of IVF and IUI covers the treatment side, and endometrial polyps and IVF covers a different structural finding with a weaker evidence base.